n Southern African Journal of HIV Medicine - Message from the Executive
|Article Title||Message from the Executive|
|Journal||Southern African Journal of HIV Medicine|
|Publication Date||Sep 2013|
Fellow HIV Clinicians, by now I am sure that most of you know that the World Health Organization (WHO) issued new guidelines. One of the most important differences is that these guidelines suggest initiating HIV-positive individuals on antiretroviral therapy (ART) at a CD4+ count of 500 cells/µl. This has caused much debate. With fixed-dose combination (FDC) treatment (one pill once daily) and medications with low side-effect profiles now available, many of the arguments for delayed therapy have fallen away. However, there is no clear clinical evidence of a benefit to starting ART earlier.
Article metrics loading...